Low-dose aspirin therapy for cardiovascular prevention: quantification and consequences of poor compliance or discontinuation.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Works in American Journal of Cardiovascular Drugs, 2010, Vol 10, Issue 2
Results: 11
1
2
Predictors of annual pharmaceutical costs in Australia for community-based individuals with, or at risk of, cardiovascular disease: analysis of Australian data from the REACH registry.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
3
Preservation of bioavailability of ingredients and lack of drug-drug interactions in a novel five-ingredient polypill (POLYCAP): a five-arm phase I crossover trial in healthy volunteers.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
4
Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
5
Low-Dose AspirinTherapy forCardiovascular Prevention.
- Published in:
- American Journal of Cardiovascular Drugs, 2010, v. 10, n. 2, p. 125, doi. 10.2165/11318440-000000000-00000
- By:
- Publication type:
- Article
6
Heterogeneity of Efficacy and Safety of Antiplatelet Therapy in Cardiovascular and Cerebrovascular Disease.
- Published in:
- American Journal of Cardiovascular Drugs, 2010, v. 10, n. 2, p. 115, doi. 10.2165/11319580-000000000-00000
- By:
- Publication type:
- Article
7
Extent of Control of Cardiovascular Risk Factors and Adherence to Recommended Therapies in US Multiethnic Adults with Coronary Heart Disease.
- Published in:
- American Journal of Cardiovascular Drugs, 2010, v. 10, n. 2, p. 109, doi. 10.2165/11535240-000000000-00000
- By:
- Publication type:
- Article
8
Ethnicity/Race, Use of Pharmacotherapy, Scope of Physician-Ordered Cholesterol Screening, and Provision of Diet/Nutrition or Exercise Counseling during US Office-Based Visits by Patients with Hyperlipidemia.
- Published in:
- American Journal of Cardiovascular Drugs, 2010, v. 10, n. 2, p. 105, doi. 10.2165/11532820-000000000-00000
- By:
- Publication type:
- Article
9
Preservation of Bioavailability of Ingredients and Lack of Drug-Drug Interactions in a Novel Five-Ingredient Polypill (Polycap).
- Published in:
- American Journal of Cardiovascular Drugs, 2010, v. 10, n. 2, p. 96, doi. 10.2165/11532170-000000000-00000
- By:
- Publication type:
- Article
10
Predictors of Annual Pharmaceutical Costs in Australia for Community-Based Individuals with, or at Risk of, Cardiovascular Disease.
- Published in:
- American Journal of Cardiovascular Drugs, 2010, v. 10, n. 2, p. 85, doi. 10.2165/11530670-000000000-00000
- By:
- Publication type:
- Article
11
Efficacy and Safety of Fenofibric Acid Co-Administered with Low- or Moderate-Dose Statin in Patients with Mixed Dyslipidemia and Type 2 Diabetes Mellitus.
- Published in:
- American Journal of Cardiovascular Drugs, 2010, v. 10, n. 2, p. 73, doi. 10.2165/10061630-000000000-00000
- By:
- Publication type:
- Article